Lune Pharma Private Limited
About Lune Pharma Private Limited
Data last updated:
Lune Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 November 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2022PTC258443.
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Sanjeev Raj Singh and Anand Shaw.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Sebagram Pally Belgharia, Kolkata, West Bengal, India – 700056.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.48 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.59 Cr (net margin -107.1%) and EBITDA of -₹1.58 Cr (EBITDA margin -106.6%).
The company has about 30 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 Sebagram Pally Belgharia, Kolkata, West Bengal, India – 700056
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lune Pharma Private Limited
The main business activity of Lune Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lune Pharma Private Limited FY 2025 filings available
Lune Pharma Private Limited reported revenue of ₹1.48 Cr (up 197% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lune Pharma Private Limited
Revenue rose 197% in the latest year. EBITDA fell 646% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Lune Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹1.58 Cr | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.59 Cr | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Lune Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -106.6% | •••• | •••• |
| Net Profit Margin | -107.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lune Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Lune Pharma Private Limited
Lune Pharma has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Raj Singh Also directs: DCP Developers Private Limited, Treaty Exim Project Private Limited, Pranita Realty Navnirman Private Limited and 1 more | Director | 25 Nov 2022 | 3 Years 10 Months | Current |
| Anand Shaw | Director | 25 Nov 2022 | 3 Years 10 Months | Current |
| Dinesh Sharma | Director | 25 Nov 2022 | 3 Years 10 Months | Current |
| Biswadip Dutta | Director | 03 Apr 2024 | 2 Years 6 Months | Current |
| Soumi Dutta Kanrar | Director | 18 Apr 2024 | 2 Years 6 Months | Current |
| Kousik Kanrar | Director | 01 Apr 2024 | 2 Years 6 Months | Current |
Peer Comparison of Lune Pharma Private Limited
Lune Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dayal Stone Crusher Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 105.0% | •••• | Gurugram, Haryana, India |
| Softtreat Healthcare Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Thane, Maharashtra, India |
| Larom Organics Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Sanand, Gujarat, India |
| Actiff Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2019) | •••• | •••• | 31.0% | •••• | Nallasopara West, Maharashtra, India |
| Punrise Foods Private Limited | ₹1.48 Cr (FY 2019) | •••• | •••• | •••• | Batala, Punjab, India | |
| Lune Pharma Private Limited this company | ₹1.48 Cr (FY 2025) | •••• | •••• | 197.0% | •••• | Kolkata, West Bengal, India |
| Redkart Sublime Rooms and Shopping Private Limited | ₹1.48 Cr (FY 2019) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Sarva Solutions Services Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Bangalore, Karnataka, India |
| Itfi Industries Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | New Delhi, Delhi, India |
| Chirai Technologies Private Limited | ₹1.48 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Octis Healthcare Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Vikas Nagar, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Lune Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Lune Pharma Private Limited
Lune Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lune Pharma Private Limited
Employment history and EPFO contributions of people linked to Lune Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lune Pharma Private Limited
Lune Pharma Private Limited has 8 board changes on record since 2022: 7 appointments and 1 cessation. The latest: Soumi Dutta Kanrar was appointed as Director on 18 Apr 2024.
Credit Ratings, Litigation & Regulatory Alerts for Lune Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lune Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lune Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lune Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lune Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lune Pharma Private Limited
Lune Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 November 2022 (4+ years old) and is registered under CIN U24290WB2022PTC258443.
Lune Pharma reported revenue of ₹1.48 Cr for FY 2025 (up 197% YoY).
Lune Pharma has 6 current directors:
- Sanjeev Raj Singh - Director
- Anand Shaw - Director
- Dinesh Sharma - Director
- Biswadip Dutta - Director
- Soumi Dutta Kanrar - Director
- Kousik Kanrar - Director
Lune Pharma reported a net loss of ₹1.59 Cr (net margin -107.1%) and EBITDA of -₹1.58 Cr (EBITDA margin -106.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Lune Pharma is U24290WB2022PTC258443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lune Pharma was incorporated on 25 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Lune Pharma by revenue are Dayal Stone Crusher Private Limited, Softtreat Healthcare Private Limited, Larom Organics Private Limited, Actiff Pharmaceuticals Private Limited, Punrise Foods Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Soumi Dutta Kanrar was appointed as Director on 18 Apr 2024. Biswadip Dutta was appointed as Director on 03 Apr 2024. Kousik Kanrar was appointed as Director on 01 Apr 2024. Lune Pharma has 8 board changes on record in total.
The registered office of Lune Pharma is at 1 Sebagram Pally Belgharia, Kolkata, West Bengal, India – 700056.
Lune Pharma has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh.
Lune Pharma operates in the chemicals industry, in the manufacturing segment.